Catalyst Wire Dossier Catalyst Wire Dossier

Thrombomodulin

recombinant human thrombomodulin
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Thrombomodulin, covering 2025-09-09 to 2025-09-09. Get the full timeline:

Most recent: Clinical Trial Update: Pilot Study to evaluateThrombomodulin to Rule Out Giant Cell Arteritis (GCA) in Polymyalgia Rheumatica (PMR) Patients. (THROPIQ)

See pricing